Please find the attached documents.
Shareholder Registration - https://pharmala.ca/assets-documents/MDMA_SUPPLEMENTAL_2026.pdf
Form of Proxy - https://pharmala.ca/assets-documents/MDMA-Proxy-Final_5.27.26.pdf
Voting Instruction Form - https://pharmala.ca/assets-documents/MDMA-VIF-Final_5.27.26.pdf
Notice of Meeting - https://pharmala.ca/assets-documents/2-MDMA-Notice-of-Meeting-AGSM-Final.pdf
Form of Proxy - https://pharmala.ca/assets-documents/MDMA-Proxy-Final_5.27.26.pdf
Meeting Information Circular -https://pharmala.ca/assets-documents/1-MDMA-2026-AGSM-Circular-Final-Compiled.pdf
Interim
FS - https://pharmala.ca/assets-documents/1A-Pharmala_FS_Q2-26_FINAL-1.pdf
MDA - https://pharmala.ca/assets-documents/1B-Pharmala_Q2_2026_MDA_FINAL-1.pd
Management Certifications:
52-109FV2 – Certification of interim filings – CFO - https://pharmala.ca/assets-documents/MDMA-Q2-CFO-Feb28-2026.pdf
52-109FV2 – Certification of interim filings – CEO - https://pharmala.ca/assets-documents/MDMA-Q2-CEO-Feb28-2026.pdf
Year-End:
FS - https://pharmala.ca/assets-documents/Pharmala_FS_Annual_2025_v3-3.pdf
MDA - https://pharmala.ca/assets-documents/Pharmala_Q4_2025_MD_A_v2-2.pdf
Management Certifications:
52-109FV2 – Certification of interim filings – CFO - https://pharmala.ca/assets-documents/MDMA-CFO-Aug31-2025.pdf
52-109FV2 – Certification of interim filings – CEO - https://pharmala.ca/assets-documents/MDMA-CEO-Aug31-2025.pdf